plicamycin has been researched along with oligonucleotides in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cogan, JG; Kelm, RJ; Polikandriotis, JA; Strauch, AR; Subramanian, SV | 1 |
| Ahn, SY; Cho, CH; Koh, GY; Lee, HJ; Lee, IK; Lee, S; Park, KG; Park, SK | 1 |
| Qin, K; Rosenfield, RL | 1 |
3 other study(ies) available for plicamycin and oligonucleotides
| Article | Year |
|---|---|
Vascular smooth muscle alpha-actin gene transcription during myofibroblast differentiation requires Sp1/3 protein binding proximal to the MCAT enhancer.
Topics: Actins; Amino Acid Motifs; Animals; Base Sequence; Binding Sites; Binding, Competitive; Blotting, Northern; Blotting, Western; Cell Differentiation; Cell Nucleus; Cells, Cultured; COS Cells; DNA; DNA-Binding Proteins; Drosophila; Endothelium, Vascular; Enhancer Elements, Genetic; Extracellular Matrix; Fibroblasts; Genes, Reporter; Humans; Immunoblotting; Mice; Molecular Sequence Data; Muscle, Smooth; Muscles; Mutation; Oligonucleotides; Plasmids; Plicamycin; Protein Binding; Rats; Sp1 Transcription Factor; Sp3 Transcription Factor; Transcription Factors; Transcription, Genetic; Transfection; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression.
Topics: Animals; Arteries; Blotting, Western; Cell Line; Cell Line, Tumor; Cells, Cultured; Chemokine CX3CL1; Chemokines, CX3C; Densitometry; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Immunohistochemistry; Intestinal Mucosa; Male; Membrane Proteins; Myocardium; NF-kappa B; Oligonucleotides; Phosphatidylinositol 3-Kinases; Plicamycin; Rats; Rats, Sprague-Dawley; Ribonucleases; RNA, Messenger; Sp1 Transcription Factor; Time Factors; Transcriptional Activation; Tumor Necrosis Factor-alpha | 2004 |
Characterization of the basal promoter element of the human type 5 17beta-hydroxysteroid dehydrogenase gene.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; 5' Flanking Region; Aldo-Keto Reductase Family 1 Member C3; Base Sequence; Blotting, Western; Cell Line, Tumor; Colforsin; DNA Primers; DNA-Binding Proteins; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Enzymologic; Humans; Hydroxyprostaglandin Dehydrogenases; Luciferases; Molecular Sequence Data; Oligonucleotides; Plicamycin; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sequence Alignment; Sp1 Transcription Factor; Sp3 Transcription Factor; Transcription Factors; Transfection; Trinucleotide Repeats | 2005 |